Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T00:20:22.238Z Has data issue: false hasContentIssue false

Question-and-Answer Session

Published online by Cambridge University Press:  07 November 2014

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Expert Panel Supplement
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Tohen, MF, Baker, RW, Altshuler, LL et al. , Olanzapine versus divalproex in acute mania. Am J Psychiatry. 2002;159:10111017.CrossRefGoogle ScholarPubMed
2.Zajecka, JM, Weisler, R, Sachs, G, Swann, AC, Wozniak, P, Sommerville, KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002;63:11481155.CrossRefGoogle ScholarPubMed
3.Soutullo, CA, DelBello, MP, Ochsner, JE et al. , Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord. 2002;70:323327.CrossRefGoogle ScholarPubMed
4.Scheffer, RE, Kowatch, RA, Carmody, T, Rush, AJ. A randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder with mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162:5864.CrossRefGoogle ScholarPubMed